Bridgeway Capital Management’s Immuneering IMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $322K | Buy |
95,449
+35,000
| +58% | +$118K | 0.01% | 853 |
|
|
2025
Q1 | $91.9K | Buy |
60,449
+9,100
| +18% | +$13.8K | ﹤0.01% | 1051 |
|
|
2024
Q4 | $113K | Buy |
51,349
+22,400
| +77% | +$49.3K | ﹤0.01% | 1097 |
|
|
2024
Q3 | $72.1K | Sell |
28,949
-25,000
| -46% | -$62.3K | ﹤0.01% | 1189 |
|
|
2024
Q2 | $69.1K | Sell |
53,949
-60,100
| -53% | -$76.9K | ﹤0.01% | 1193 |
|
|
2024
Q1 | $330K | Buy |
114,049
+75,000
| +192% | +$217K | 0.01% | 1019 |
|
|
2023
Q4 | $287K | Hold |
39,049
| – | – | 0.01% | 1068 |
|
|
2023
Q3 | $300K | Hold |
39,049
| – | – | 0.01% | 1008 |
|
|
2023
Q2 | $396K | Hold |
39,049
| – | – | 0.01% | 970 |
|
|
2023
Q1 | $379K | Buy |
39,049
+4,100
| +12% | +$39.8K | 0.01% | 951 |
|
|
2022
Q4 | $170K | Hold |
34,949
| – | – | ﹤0.01% | 1125 |
|
|
2022
Q3 | $500K | Hold |
34,949
| – | – | 0.01% | 897 |
|
|
2022
Q2 | $189K | Buy |
+34,949
| New | +$189K | ﹤0.01% | 1100 |
|